Liraglutide
Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
Novo Nordisk · Phase 3 · Status n/r · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide | Obesity or overweight | n/r | 28 | n/r | n/r |
| placebo | Obesity or overweight | n/r | 28 | n/r | n/r |